Protease Inhibitors
Links shared publicly online about this topic
Neurology Article | Protease Inhibitors
mdlinx.com — “Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events” View full resource at mdlinx.com
Most Recently Shared on May 9, 2011 at 8:31 pm By:
Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Advers... http://bit.ly/jXIxyc #neuro
Oncology Article | Protease Inhibitors
mdlinx.com — “Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events” View full resource at mdlinx.com
Most Recently Shared on May 9, 2011 at 3:50 pm By:
Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adv... http://bit.ly/jH5yqf #oncology
Oncology Article | Protease Inhibitors
mdlinx.com — “Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1” View full resource at mdlinx.com
Most Recently Shared on March 28, 2011 at 6:03 am By:
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via inductio... http://bit.ly/f9AIEf #oncology
Family Medicine Article | Protease Inhibitors
mdlinx.com — “Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis” View full resource at mdlinx.com
Most Recently Shared on December 16, 2010 at 8:21 am By:
Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis: Ga... http://bit.ly/gX6zTf #FamPractice
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)
theannals.com — “Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)” View full resource at theannals.com
Most Recently Shared on August 10, 2011 at 4:57 am By:
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September): OBJECTIVE:To review the p... http://bit.ly/rrZDSP
HCV New Drug Research: Hepatitis C; resistance to protease inhibitors
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; resistance to protease inhibitors” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on February 6, 2011 at 12:22 am By:
Hepatitis C; resistance to protease inhibitors http://goo.gl/fb/77cXN
HCV New Drug Research: Protease Inhibitor-Resistant Hepatitis C Virus
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Protease Inhibitor-Resistant Hepatitis C Virus” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on November 16, 2010 at 1:39 am By:
Protease Inhibitor-Resistant Hepatitis C Virus http://goo.gl/fb/NBu4H
Gastroenterology Article | Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin
mdlinx.com — “Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin” View full resource at mdlinx.com
Most Recently Shared on September 28, 2011 at 9:28 pm By:
Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Ator... http://t.co/PpLkeotL #GI
HIV Protease Inhibitors: Present and Future - QualityPoint Technologies
qualitypointtech.net — “This article gives an overview of some of the newest protease inhibitors available for HIV infected patients. Future Virology” View full resource at qualitypointtech.net
Most Recently Shared on July 11, 2011 at 3:00 pm By:
HIV Protease Inhibitors: Present and Future: This article gives an overview of some of the newest protease inhibit... http://bit.ly/psbQfq
HCV New Drug Research: Hepatitis C; resistance to protease inhibitors
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; resistance to protease inhibitors” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on February 7, 2011 at 1:45 am By:
HCV New Drug Research: Hepatitis C; resistance to protease inhibitors http://t.co/C8tN60i
New Colcrys dosing when administered with protease inhibitors - ONA
oncologynurseadvisor.com — “URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 7, 2010 at 2:55 pm By:
New Colcrys dosing when administered with protease inhibitors http://goo.gl/fb/qcntg
New Colcrys dosing when administered with protease inhibitors - MPR
empr.com — “URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine).” View full resource at empr.com
Most Recently Shared on May 7, 2010 at 3:59 pm By:
MPR News: New Colcrys dosing when administered with protease inhibitors: URL Pharma, Inc., today announced that th... http://bit.ly/apQoWm
Victrelis: protease inhibitor launched for hepatitis C | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on August 30, 2011 at 3:56 pm By:
Victrelis, first protease inhibitor for hepatitis C, now listed in MIMS: http://t.co/FlBPTMK
Incivo: hepatitis C protease inhibitor launched | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on November 4, 2011 at 2:10 pm By:
MIMS summary of Incivo (telaprevir), new hepatitis C protease inhibitor: http://t.co/h0ENYV6B
HCV New Drug Research: HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on October 30, 2010 at 1:22 pm By:
HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127 http://goo.gl/fb/IsRuL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

